Pharma's expensive gaming of the drug patent system is successfully countered by the Medicines Patent Pool, which increases global access and rewards innovation
The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
Lucy Xiaolu Wang, Assistant Professor of Resource Economics, UMass Amherst
• conversation
Dec. 5, 2022 • ~11 min
Dec. 5, 2022 • ~11 min
How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakers
India and South Africa are pressing the World Trade Organization to waive patent rights to help ramp up vaccine production. There's a better solution.
Dalindyebo Shabalala, Associate Professor, University of Dayton •
conversation
April 14, 2021 • ~9 min
April 14, 2021 • ~9 min
Patent system often stifles the innovation it was designed to encourage
Too many patents and too little information about them makes it hard for the system to weed out patents that unfairly block inventors.
Janet Freilich, Associate Professor of Law, Fordham University •
conversation
March 16, 2021 • ~11 min
March 16, 2021 • ~11 min
The iconic American inventor is still a white male – and that's an obstacle to race and gender inclusion
The story of the invention in America typically features larger-than-life caricatures of white men like Thomas Edison while largely ignoring the contributions of women and people of color.
Anjali Vats, Associate Professor of Communication and African and African Diaspora Studies and Associate Professor of Law (By Courtesy), Boston College •
conversation
Dec. 8, 2020 • ~9 min
Dec. 8, 2020 • ~9 min
/
1